HK33793A - Oral sustained release forms of carbamazepine - Google Patents

Oral sustained release forms of carbamazepine Download PDF

Info

Publication number
HK33793A
HK33793A HK337/93A HK33793A HK33793A HK 33793 A HK33793 A HK 33793A HK 337/93 A HK337/93 A HK 337/93A HK 33793 A HK33793 A HK 33793A HK 33793 A HK33793 A HK 33793A
Authority
HK
Hong Kong
Prior art keywords
carbamazepine
water
core
therapeutic system
drug
Prior art date
Application number
HK337/93A
Other languages
English (en)
Inventor
Chandra Khanna Satish
Ruttimann Theresa
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK33793A publication Critical patent/HK33793A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
HK337/93A 1986-08-07 1993-04-08 Oral sustained release forms of carbamazepine HK33793A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH3172/86A CH668187A5 (de) 1986-08-07 1986-08-07 Therapeutisches system mit systemischer wirkung.

Publications (1)

Publication Number Publication Date
HK33793A true HK33793A (en) 1993-04-16

Family

ID=4250176

Family Applications (1)

Application Number Title Priority Date Filing Date
HK337/93A HK33793A (en) 1986-08-07 1993-04-08 Oral sustained release forms of carbamazepine

Country Status (30)

Country Link
US (1) US4857336A (de)
JP (1) JP2592460B2 (de)
KR (1) KR950006219B1 (de)
AT (1) AT397344B (de)
AU (1) AU597403B2 (de)
BE (1) BE1000235A3 (de)
CA (1) CA1302267C (de)
CH (1) CH668187A5 (de)
DD (1) DD285718A5 (de)
DE (1) DE3725824C2 (de)
DK (1) DK175497B1 (de)
ES (1) ES2007100A6 (de)
FI (1) FI86143C (de)
FR (1) FR2602425B1 (de)
GB (1) GB2193632B (de)
GR (1) GR871234B (de)
HK (1) HK33793A (de)
HU (1) HU206978B (de)
IE (1) IE59718B1 (de)
IL (1) IL83386A (de)
IT (1) IT1215618B (de)
LU (1) LU86966A1 (de)
MY (1) MY100767A (de)
NL (1) NL194780C (de)
NO (1) NO173726C (de)
NZ (1) NZ221347A (de)
PH (1) PH25090A (de)
PT (1) PT85489B (de)
SE (1) SE502590C2 (de)
ZA (1) ZA875804B (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE72111T1 (de) * 1987-01-14 1992-02-15 Ciba Geigy Ag Therapeutisches system fuer schwerloesliche wirkstoffe.
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
US4824675A (en) * 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
NZ226179A (en) * 1987-09-24 1991-04-26 Merck & Co Inc Controlled porosity osmotic pump for sustained release of pharmaceutical agents
US5019397A (en) * 1988-04-21 1991-05-28 Alza Corporation Aqueous emulsion for pharmaceutical dosage form
JP2893191B2 (ja) * 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US5035897A (en) * 1989-09-05 1991-07-30 Alza Corporation Dosage form for delivering soluble or insoluble drugs
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
US5643591A (en) * 1991-01-16 1997-07-01 Fmc Corporation Solid dosage forms
FI933223L (fi) * 1991-01-16 1993-07-15 Fmc Corp Baerare foer aktiva aemnen och med denna framstaellda fasta doseringsformer
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US20040191314A1 (en) * 1994-04-28 2004-09-30 Frank Jao Antiepileptic dosage form and process for protecting antiepileptic drug
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
DE4423078B4 (de) * 1994-07-01 2005-01-13 Awd.Pharma Gmbh & Co. Kg Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
TW487582B (en) * 1995-08-11 2002-05-21 Nissan Chemical Ind Ltd Method for converting sparingly water-soluble medical substance to amorphous state
US5800832A (en) * 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
US6296873B1 (en) 1997-01-23 2001-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release delivery system for carbamazephine derivatives
US5980942A (en) * 1997-01-23 1999-11-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release matrix tablet formulations of carbamazepine
US20020022056A1 (en) 1997-02-14 2002-02-21 Burkhard Schlutermann Oxacarbazepine film-coated tablets
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
WO1999015172A1 (de) 1997-09-25 1999-04-01 Bayer Aktiengesellschaft Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
DE69923675T2 (de) * 1998-04-29 2006-05-11 Virotex Corp., Fort Collins Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist
US6706283B1 (en) * 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
CA2725833A1 (en) * 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Spaced drug delivery system
IN190699B (de) * 2001-02-02 2003-08-16 Sun Pharmaceutical Ind Ltd
US20040156900A1 (en) * 2001-04-10 2004-08-12 Shanghvi Dilip Shantilal Time pulsed release composition
RU2189225C1 (ru) * 2001-09-14 2002-09-20 Нестерук Владимир Викторович Лекарственное средство на основе карбамазепина
US20030161882A1 (en) * 2002-02-01 2003-08-28 Waterman Kenneth C. Osmotic delivery system
US20030175346A1 (en) * 2002-02-01 2003-09-18 Anne Billotte Osmotic delivery system
US6572889B1 (en) 2002-03-07 2003-06-03 Noveon Ip Holdings Corp. Controlled release solid dosage carbamazepine formulations
AU2003231919A1 (en) * 2002-03-14 2003-09-22 Sun Pharmaceutical Industries Limited Oral controlled drug delivery system containing carbamazepine
US7785627B2 (en) * 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) * 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US20060210633A1 (en) * 2003-04-03 2006-09-21 Sun Pharmaceutical Industries Limited Programmed drug delivery system
RU2240798C1 (ru) * 2003-06-25 2004-11-27 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая композиция, обладающая противосудорожным и психотропным действием, и способ ее получения
EP1690540A1 (de) * 2005-02-15 2006-08-16 Neuro3D Zusammensetzung enthaltend Ocaperidon
WO2006116247A1 (en) * 2005-04-25 2006-11-02 Teva Pharmaceuticals Usa, Inc. Extended release formulations
US20070071819A1 (en) * 2005-05-30 2007-03-29 Kesarwani Amit K Multiple unit modified release compositions of carbamazepine and process for their preparation
AU2007275581B2 (en) 2006-07-21 2011-09-08 Biodelivery Sciences International, Inc. Transmucosal delivery devices with enhanced uptake
US20090143362A1 (en) * 2007-12-04 2009-06-04 Barabde Umesh Vinayakrao Carbamazepine formulations
EP2231169B1 (de) * 2007-12-06 2016-05-04 Bend Research, Inc. Pharmazeutische zusammensetzungen mit nanopartikeln und resuspensionsmaterial
EP2240162A4 (de) 2007-12-06 2013-10-09 Bend Res Inc Nanoteilchen mit einem nicht-ionisierbaren polymer und einem amin-funktionalisierten methacrylat-copolymer
WO2013026064A1 (en) 2011-08-18 2013-02-21 Biodelivery Sciences International, Inc. Abuse-resistant mucoadhesive devices for delivery of buprenorphine
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4431641A (en) * 1980-10-17 1984-02-14 Ciba-Geigy Corporation Pharmaceutical compositions having antiepileptic and antineuralgic action
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
CH649080A5 (de) * 1981-04-16 1985-04-30 Ciba Geigy Ag 5h-dibenz(b,f)azepin-5-carboxamide als mittel zur prophylaxe und behandlung von zerebraler leistungsinsuffizienz.
US4553973A (en) * 1982-07-12 1985-11-19 Alza Corporation Process for preparing osmotic device
GB2150830B (en) * 1983-12-05 1987-08-19 Alza Corp Drug dispenser
US4716031A (en) * 1984-03-21 1987-12-29 Alza Corporation Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug
US4685918A (en) * 1985-02-01 1987-08-11 Merck & Co., Inc. Lipid osmotic pump

Also Published As

Publication number Publication date
BE1000235A3 (fr) 1988-09-20
NO873298L (no) 1988-02-08
US4857336A (en) 1989-08-15
MY100767A (en) 1991-02-14
JP2592460B2 (ja) 1997-03-19
IL83386A (en) 1992-01-15
NO873298D0 (no) 1987-08-06
PT85489A (en) 1987-09-01
ZA875804B (en) 1988-02-08
FI86143C (fi) 1992-07-27
AU597403B2 (en) 1990-05-31
IT8748270A0 (it) 1987-08-05
AT397344B (de) 1994-03-25
CH668187A5 (de) 1988-12-15
FI873409A0 (fi) 1987-08-05
SE502590C2 (sv) 1995-11-20
NL8701857A (nl) 1988-03-01
DK175497B1 (da) 2004-11-15
GB2193632A (en) 1988-02-17
NO173726B (no) 1993-10-18
ES2007100A6 (es) 1989-06-01
SE8703034D0 (sv) 1987-08-03
FR2602425B1 (fr) 1990-09-14
GB2193632B (en) 1990-04-25
GR871234B (en) 1987-12-08
DK410787A (da) 1988-02-08
NL194780C (nl) 2003-03-04
JPS6344525A (ja) 1988-02-25
PT85489B (pt) 1990-06-29
HU206978B (en) 1993-03-01
IT1215618B (it) 1990-02-22
DE3725824A1 (de) 1988-02-11
ATA199387A (de) 1993-08-15
DE3725824C2 (de) 1998-12-17
FI86143B (fi) 1992-04-15
NO173726C (no) 1994-01-26
IE59718B1 (en) 1994-03-23
FI873409A7 (fi) 1988-02-08
KR880002511A (ko) 1988-05-09
GB8717643D0 (en) 1987-09-03
CA1302267C (en) 1992-06-02
FR2602425A1 (fr) 1988-02-12
PH25090A (en) 1991-02-19
LU86966A1 (fr) 1989-03-08
IE872110L (en) 1988-02-07
KR950006219B1 (ko) 1995-06-12
DK410787D0 (da) 1987-08-06
NL194780B (nl) 2002-11-01
DD285718A5 (de) 1991-01-03
HUT44930A (en) 1988-05-30
IL83386A0 (en) 1987-12-31
NZ221347A (en) 1989-12-21
SE8703034L (sv) 1988-02-08
AU7661787A (en) 1988-02-11

Similar Documents

Publication Publication Date Title
IE872110L (en) Oral therapeutic system having systemic action
US4898733A (en) Layered, compression molded device for the sustained release of a beneficial agent
AU1227899A (en) Osmotic medicament releasing system
PT1021171E (pt) Sistema de administracao de farmacos no tracto gastrointestinal de libertacao total prolongada
CA2370202C (en) Gum pad for delivery of medication to mucosal tissues
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
NO872381D0 (no) Fremgangsmaate for fremstilling av langsomt frigivende preparater.
MX10086A (es) Un sistema para la administracion de substancias activas no solubles en agua y procedimiento para su preparacion.
DK0754452T3 (da) Farmaceutisk præparat i form af en overtrukket kapsel, der frigives i den nedre del af fordøjelsessystemet
UA26988C2 (uk) Спосіб седативhого впливу hа пацієhта і траhсдермальhа терапевтичhа система
LU91037I2 (fr) Somatulina autogel
DE3770937D1 (de) Tablette zur pharmazeutischen anwendung sukzessiver freisetzung.
GR1002564B (el) Στερεα απο του στοματος χορηγουμενη φαρμακευτικη μορφη δοσιμετρησεως προγραμματισμενου ρυθμου απελευθερωσεως.
NZ508567A (en) Methods and devices for providing prolonged drug therapy
IE882898L (en) Solubility modulated drug delivery device
ATE282406T1 (de) Arzneimittel und verfahren zur behandlung von intrazellulären infektionen
US20030064101A1 (en) Floating osmotic device for controlled release drug delivery
IE894049L (en) Therapeutically active substituted benzimidazole and process¹for its preparation
CA2383212A1 (en) Controlled release oral dosage suitable for oral administration
HU9301672D0 (en) Method for manufacturing solid dosing forms of medicaments with controlled releasing of active agents
US5082665A (en) Anti-snoring formulations using yohimbine
EE03954B1 (et) Toimeaine pärsitud vabanemisega karbamasepiini ravimvormi valmistamise meetod
RU2002109236A (ru) Композиции с контрлируемым высвобождением для перорального применения
DE59910944D1 (de) Transdermales therapeutisches system zur anwendung von candesartan
DE50000864D1 (de) Verwendung von desoxypeganin zur behandlung von drogenabhängigkeit

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20070723